Zinc remodels mitochondrial network through SIRT3/Mfn2-dependent mitochondrial transfer in ameliorating spinal cord injury DOI
Hui Guo, Liqing Chen,

Zhiru Zou

et al.

European Journal of Pharmacology, Journal Year: 2024, Volume and Issue: 968, P. 176368 - 176368

Published: Feb. 3, 2024

Language: Английский

Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview DOI
Eman E. Alshial,

Muhammad Idris Abdulghaney,

Al-Hassan Soliman Wadan

et al.

Life Sciences, Journal Year: 2023, Volume and Issue: 334, P. 122257 - 122257

Published: Nov. 8, 2023

Language: Английский

Citations

44

Mitochondrial-Derived Vesicles: The Good, the Bad, and the Ugly DOI Open Access
Anna Picca, Flora Guerra, Riccardo Calvani

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(18), P. 13835 - 13835

Published: Sept. 8, 2023

Mitophagy is crucial for maintaining mitochondrial quality. However, its assessment in vivo challenging. The endosomal-lysosomal system a more accessible pathway through which subtypes of extracellular vesicles (EVs), also contain constituents, are released disposal. inclusion components into EVs occurs the setting mild damage and during impairment lysosomal function. By releasing mitochondrial-derived (MDVs), cells limit unload damage-associated molecular patterns with proinflammatory activity. Both positive negative effects on recipient have been described. Whether this due to production other than those containing mitochondria, such as MDVs, holding specific biological functions currently unknown. Evidence existence different MDV has produced. their characterization not always pursued, would be relevant exploring dynamics quality control health disease. Furthermore, classification may instrumental understanding roles promoting implementation biomarkers clinical studies.

Language: Английский

Citations

25

Insight into the effect of biomaterials on osteogenic differentiation of mesenchymal stem cells: A review from a mitochondrial perspective DOI
Ziyi Feng,

Meiqi Jin,

Junzhi Liang

et al.

Acta Biomaterialia, Journal Year: 2023, Volume and Issue: 164, P. 1 - 14

Published: March 25, 2023

Language: Английский

Citations

24

Mitochondrial Quantity and Quality in Age-Related Sarcopenia DOI Open Access
Emanuele Marzetti, Riccardo Calvani, Hélio José Coelho‐Júnior

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(4), P. 2052 - 2052

Published: Feb. 8, 2024

Sarcopenia, the age-associated decline in skeletal muscle mass and strength, is a condition with complex pathophysiology. Among factors underlying development of sarcopenia are progressive demise motor neurons, transition from fast to slow myosin isoform (type II type I fiber switch), decrease satellite cell number function. Mitochondrial dysfunction has been indicated as key contributor myocyte loss physical performance aging. Several systems have implicated regulation plasticity trophism such fine-tuned between stimulator protein synthesis, mechanistic target rapamycin (mTOR), inhibitor mTOR, AMP-activated kinase (AMPK), that promotes catabolism. Here, we provide an overview molecular mechanisms linking mitochondrial signaling quality homeostasis discuss main pathways elicited by their imbalance during age-related wasting. We also lifestyle interventions (i.e., exercise nutrition) may be exploited preserve function aged muscle. Finally, illustrate emerging possibility rescuing tissue through transplantation.

Language: Английский

Citations

12

Mitochondria in the Central Nervous System in Health and Disease: The Puzzle of the Therapeutic Potential of Mitochondrial Transplantation DOI Creative Commons
Kuldeep Tripathi, Dorit Ben‐Shachar

Cells, Journal Year: 2024, Volume and Issue: 13(5), P. 410 - 410

Published: Feb. 27, 2024

Mitochondria, the energy suppliers of cells, play a central role in variety cellular processes essential for survival or leading to cell death. Consequently, mitochondrial dysfunction is implicated numerous general and CNS disorders. The clinical manifestations include metabolic disorders, immune system, tumorigenesis, neuronal behavioral abnormalities. In this review, we focus on CNS, which has unique characteristics therefore highly dependent mitochondria. First, review mitochondria development, synaptogenesis, plasticity, behavior as well their adaptation intricate connections between different types brain. Then, sparse knowledge mechanisms exogenous uptake describe attempts determine half-life transplantation long-term effects sprouting, proteome, behavior. We further discuss potential serve tool study causal link activity Next, transplantation’s therapeutic various Finally, basic reverse—translation challenges approach that currently hinder use transplantation.

Language: Английский

Citations

10

Restoring Mitochondrial Function and Muscle Satellite Cell Signaling: Remedies against Age-Related Sarcopenia DOI Creative Commons
Emanuele Marzetti, Biliana Lozanoska‐Ochser, Riccardo Calvani

et al.

Biomolecules, Journal Year: 2024, Volume and Issue: 14(4), P. 415 - 415

Published: March 28, 2024

Sarcopenia has a complex pathophysiology that encompasses metabolic dysregulation and muscle ultrastructural changes. Among the drivers of intracellular changes fibers in sarcopenia, mitochondria their quality control pathways play relevant roles. Mononucleated stem cells/satellite cells (MSCs) have been attributed critical role repair after an injury. The involvement supporting MSC-directed is unclear. There evidence reduction mitochondrial biogenesis blunts repair, thus indicating delivery functional to injured muscles can be harnessed limit fibrosis enhance restoration function. Injection autologous respiration-competent from uninjured sites damaged tissue shown reduce infarct size cell survival preclinical models ischemia-reperfusion. Furthermore, incorporation donor into MSCs enhances lung cardiac repair. This strategy also tested for regeneration purposes traumatic injuries. Indeed, systemic promotes restores mass function while reducing during recovery In this review, we discuss contribution altered MSC sarcopenia illustrate prospect harnessing as therapeutic against age-related sarcopenia.

Language: Английский

Citations

9

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease DOI
Qing Yin Zheng, Hanghang Liu, Yifan Gao

et al.

Small, Journal Year: 2024, Volume and Issue: 20(29)

Published: Feb. 22, 2024

Parkinson's disease (PD) is currently the second most incurable central neurodegenerative resulting from various pathogenesis. As "energy factory" of cells, mitochondria play an extremely important role in supporting neuronal signal transmission and other physiological activities. Mitochondrial dysfunction can cause accelerate occurrence progression PD. How to effectively prevent suppress mitochondrial disorders a key strategy for treatment PD root. Therefore, emerging mitochondria-targeted therapy has attracted considerable interest. Herein, relationship between PD, causes results dysfunction, major strategies ameliorating treat are systematically reviewed. The study also prospects main challenges

Language: Английский

Citations

8

Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease DOI
Fatemeh Baharvand,

Mehryar Habibi Roudkenar,

Zahra Pourmohammadi-Bejarpasi

et al.

International Journal of Cardiology, Journal Year: 2024, Volume and Issue: 410, P. 132227 - 132227

Published: June 5, 2024

Language: Английский

Citations

8

Nanoenzyme-Anchored Mitofactories Boost Mitochondrial Transplantation to Restore Locomotor Function after Paralysis Following Spinal Cord Injury DOI

Runxiu Wei,

Yongjun Chen, Qiang Yang

et al.

ACS Nano, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 24, 2025

Mitochondrial transplantation is a significant therapeutic approach for addressing mitochondrial dysfunction in patients with spinal cord injury (SCI), yet it limited by rapid deactivation and low transfer efficiency. Here, high-quality mitochondria microfactories (HQ-Mitofactories) were constructed anchoring Prussian blue nanoenzymes onto mesenchymal stem cells effective to treat paralysis from SCI. Notably, the results demonstrated that HQ-Mitofactories could continuously produce vitality-boosting highly interconnected elongated network structures under oxidative stress scavenging excessive ROS. Furthermore, enabled efficient of injured neurons primarily via gap junctions, resulting restoration homeostasis thereby suppressing intracellular ROS burst facilitating neuronal repair. After i.v. administration, migrated cords SCI mice subsequently promoted regeneration remyelination. Consequently, HQ-Mitofactory-treated successfully recovered locomotor function within 4 weeks, 40% fully restoring walking after hindlimb paralysis. Conversely, untreated exhibited completely abolished movements. In light real-time generation even enabling targeted transfer, have promising potential context reduce SCI-related paralysis, more broadly impact field neuroregenerative medicine.

Language: Английский

Citations

1

Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases DOI Creative Commons

Mingchu Sun,

Wenhua Jiang,

Nan Mu

et al.

Journal of Translational Medicine, Journal Year: 2023, Volume and Issue: 21(1)

Published: May 25, 2023

Abstract Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in onset development CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing number improving function, has been emerged with great potential. Substantial evidence indicates that transplantation improves cardiac function outcomes patients Therefore, profound implications prevention Here, we review abnormalities occur summarize for

Language: Английский

Citations

19